These results suggest that P3155 is an inhibitor of HIF-1 that halts tumor growth by blocking tumor adaptation to hypoxia and thus can be used as a therapeutic modality for aggressive prostate cancer. The gene discussed is HIF1A; the disease is prostate cancer.